Abstract
The thermotolerant strain Streptomyces sp. HR41 was found to produce compound 1 only in a 45 °C culture, and not at the standard temperature. We previously designated this type of compound as a “heat shock metabolite” (HSM). NMR and MS analytical techniques were used to determine that the chemical structure of 1 comprised a methylated-oxazole ring and a linear chain moiety modified with a terminal amide group. Thus, 1 was shown to be a new curromycin analog, which we have designated noaoxazole (1). Compound 1 weakly activated Notch signal reporter activity without exhibiting cytotoxicity against assay cells at the same concentration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–61.
Demain AL, Sanchez S. Microbial drug discovery: 80 years of progress. J Antibiot. 2009;62:5–16.
Saito S, Atsumi K, Zhou T, Fukaya K, Urabe D, Oku N, et al. A cyclopeptide and three oligomycin-class polyketides produced by an underexplored actinomycete of the genus Pseudosporangium. Beilstein J Org Chem. 2020;16:1100–10.
Saito S, Indo K, Oku N, Komaki H, Kawasaki M, Igarashi Y. Unsaturated fatty acids and a prenylated tryptophan derivative from a rare actinomycete of the genus Couchioplanes. Beilstein J Org Chem. 2021;17:2939–49.
Saito S, Oku N, Igarashi Y. Mycetoindole, an N-acyl dehydrotryptophan with plant growth inhibitory activity from an actinomycete of the genus Actinomycetospora. J Antibiot. 2022;75:44–7.
Ohnishi Y, Ishikawa J, Hara H, Suzuki H, Ikenoya M, Ikeda H, Yamashita A, Hattori M, Horinouchi S. Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol. 2008;190:4050–60.
Ikeda H, Kazuo SY, Omura S. Genome mining of the Streptomyces avermitilis genome and development of genome-minimized hosts for heterologous expression of biosynthetic gene clusters. J Ind Microbiol Biotechnol. 2014;41:233–50.
van Keulen G, Dyson PJ. Production of specialized metabolites by Streptomyces coelicolor A3(2). Adv Appl Microbiol. 2014;89:217–66.
Ochi K, Okamoto S, Tozawa Y, Inaoka T, Hosaka T, Xu J, Kurosawa K. Ribosome engineering and secondary metabolite production. Adv Appl Microbiol. 2004;56:155–84.
Onaka H, Mori Y, Igarashi Y, Furumai T. Mycolic acid-containing bacteria induce natural-product biosynthesis in Streptomyces species. Appl Environ Microbiol. 2011;77:400–6.
Hara Y, Arai MA, Toume K, Masu H, Sato T, Komatsu K, Yaguchi T, Ishibashi M. Coculture of a pathogenic actinomycete and animal cells to produce nocarjamide, a cyclic nonapeptide with wnt signal-activating effect. Org Lett. 2018;20:5831–4.
Saito S, Kato W, Ikeda H, Katsuyama Y, Ohnishi Y, Imoto M. Discovery of “heat shock metabolites” produced by thermotolerant actinomycetes in high-temperature culture. J Antibiot. 2020;73:203–10.
Yoneyama T, Arai MA, Akamine R, Koryudzu K, Tsuchiya A, Sadhu SK, et al. Notch inhibitors from Calotropis gigantea that induce neuronal differentiation of neural stem cells. J Nat Prod. 2017;80:2453–61.
Ye Q, Jiang J, Zhan G, Yan W, Huang L, Hu Y, Su H, Tong Q, Yue M, Li H, Yao G, Zhang Y, Liu H. Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia. Sci Rep. 2016;6:26510.
Henkel T, Zeeck A. Sekundärstoffe aus dem chemischen Screening, 16. Inthomycine, neue Oxazol-triene aus Streptomyces sp. Liebigs Ann Chem. 1991;1991:367–73.
Takahashi K, Kawabata M, Uemura D, Iwadare S, Mitomo R, Nakano F, Matsuzaki A. Structure of neooxazolomycin, an antitumor antibiotic. Tetrahedron Lett. 1985;26:1077–8.
Mori T, Takahashi K, Kashiwabara M, Uemura D, Katayama C, Iwadare S, Shizuri Y, Mitomo R, Nakano F, Matsuzaki A. Structure of oxazolomycin, a novel β-lactone antibiotic. Tetrahedron Lett. 1985;26:1073–6.
Ogura M, Nakayama H, Furihata K, Shimazu A, Seto H, Otake N. Structure of a new antibiotic curromycin A produced by a genetically modified strain of Streptomyces hygroscopicus, a polyether antibiotic producing organism. J Antibiot. 1985;38:669–73.
Hayakawa Y, Yaguchi R, Akimoto M, Kimata S, Shin-Ya K. Neocurromycin A, a new GRP78 downregulator from Streptomyces sp. RAI364 J Antibiot. 2020;73:790–3.
Senapati BK. Progress in the total synthesis of inthomycins. Beilstein J Org Chem. 2021;17:58–82.
Acknowledgements
We thank Prof. Masaya Imoto at Juntendo University for providing actinomycete strains. This work was supported by the JSPS KAKENHI under Grant Number 20K15461 to SS.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Saito, S., Suzuki, S. & Arai, M.A. Noaoxazole, a new heat shock metabolite produced by thermotolerant Streptomyces sp. HR41. J Antibiot 75, 509–513 (2022). https://doi.org/10.1038/s41429-022-00551-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-022-00551-5